Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04219878
Other study ID # IRB00099710
Secondary ID 1U01PS005181
Status Completed
Phase N/A
First received
Last updated
Start date February 17, 2020
Est. completion date January 15, 2022

Study information

Verified date January 2024
Source Emory University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will use online materials and strategies to recruit 3600 Black and Hispanic men who have sex with men (MSM) and transgender women (TGW) to participate in a study evaluating the effectiveness of the Know@Home mobile app compared to control condition with respect to linkage of participants to appropriate services, as well as cost-effectiveness outcomes.


Description:

To evaluate the effectiveness of mailing out rapid HIV home-testing kits and additional testing promotion components among African-American or black and Hispanic or Latino gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW), the study "Implementation of Rapid HIV Self-Testing among MSM Project", known as iSTAMP, is being conducted in 11 US states. This study is interested in the most cost-effective ways to recruit people at high risk for HIV infection. The researchers want to study a sample of 3600 adult MSM and TGW who are not known to be living with HIV; 1800 black/African-American and 1800 Hispanic/Latino participants will be enrolled. All participants will be mailed two rapid HIV self-test kits upon randomization. All participants, regardless of study arm, will also complete a follow-up survey at the end of a 4-month follow-up period. At the end of the 4-month follow-up period, participants will be mailed a dried blood spot (DBS) collection kit for research purposes, as well as another rapid HIV self-test kit for immediate testing. Participants in each of the arms will have access to videoconferencing-delivered prevention counseling, and all participants, regardless of assigned arm, will be contacted if they report seroconversion and/or a preliminary positive test during the study period for active linkage to care.


Recruitment information / eligibility

Status Completed
Enrollment 2195
Est. completion date January 15, 2022
Est. primary completion date September 1, 2021
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria for MSM Participants: - Black/African-American race or Hispanic/Latino ethnicity - Male sex at birth - Currently identify as male - Reported anal sex with at least one man in the past 12 months - Aged 18 or over - Has an Android or Apple mobile phone with currently active service - Currently resides in a study state: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Florida, Louisiana, California, Nevada, Texas, New York - Willing to download a study participation management mobile app - Willing to provide valid contact information so that study HIV testing kits and other materials (condoms, lubricants, STI testing kits) can be mailed to participants. - Successful completion of baseline survey Exclusion Criteria for MSM Participants: - Currently participating in another HIV prevention research study or program - Has a bleeding disorder preventing use of dried blood spot testing - Has previously participated in an HIV vaccine study. - Currently taking PrEP for HIV prevention - Self-reports living with HIV - Has plans to move out of a study state during the study period (4 months) Inclusion Criteria for TGW: - Male sex at birth - Currently identify as transgender woman or female - Aged 18 or over - Has an Android or Apple mobile smartphone with currently active service - Currently resides in a study state: North Carolina, South Carolina, Georgia, Alabama, Mississippi, Florida, Louisiana, California, Nevada, Texas, New York - Willing to provide valid contact information so that study HIV testing kits and other materials (condoms, lubricants, STI testing kits) can be mailed to participants - Successful completion of baseline survey Exclusion Criteria for TGW: - Currently participating in another HIV prevention clinical trial or intervention - Has a bleeding disorder preventing use of dried blood spot testing - Has previously participated in an HIV vaccine study - Currently taking PrEP for HIV prevention - Self-reports living with HIV - Has plans to move out of a study state during the study period (4 months)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Know@Home
Participants randomly assigned to the Know@Home arm will access the features of Know@Home by downloading the app or accessing the website. The contents were developed to serve as a comprehensive mobile HIV prevention platform for MSM or TGW, with HIV prevention and care information and links to resources. This intervention arm provides an toolkit that allows users to access information about prevention services as their needs change. Participants will have access to Know@Home for the study period. The Know@Home arm will offer participants the opportunity to order free condoms and lubricant as well as an at-home sexually transmitted infection (STI) testing kit.
Other:
Self-test Kit
All participants will be shipped two at-home HIV self-tests. They will also receive a link to a previously-produced video that fully describes the specimen collection process, pointing out common errors and providing tips for successful collection. Participants will interact with study staff through phone, email, or text. Information to schedule a video HIV testing and counseling session with study staff will be made available to participants in all arms via a website, email, and/or text.

Locations

Country Name City State
United States Emory University Atlanta Georgia

Sponsors (2)

Lead Sponsor Collaborator
Emory University Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants initiating HIV treatment Effectiveness of the interventions will be assessed by linkage of participants to HIV treatment. Up to Month 4
Primary Number of participants initiating PrEP treatment Effectiveness of the interventions will be assessed by linkage of participants to PrEP treatment. Up to Month 4
Primary Number of participants testing for STIs Effectiveness of the interventions will be assessed by linkage of participants to STI testing. Up to Month 4
Primary Number of participants engaging in HIV prevention services Effectiveness of the interventions will be assessed by linkage of participants to HIV prevention services. Up to Month 4
Primary Number of participants engaging in HIV social services Effectiveness of the interventions will be assessed by linkage of participants to HIV social services. Up to Month 4
Primary Cost of different online venues for study enrollment Enrollment in the study defined as completion of the baseline survey and downloading of the study app. The cost (in US dollars) to enroll participants (online banner advertisement placement, study staff time to manage enrollment, validating participant eligibility, monitoring and evaluation of enrollment data) will be compared between the study arms. Baseline
Primary Cost of different online venues for HIV test results returned The cost (in US dollars) of HIV tests returned within 1 month of enrollment will be compared between the study arms. The costs involved with having HIV tests returned include:
Online banner advertisement placement
Study staff time managing enrollment, validating participant eligibility, monitoring and evaluation of enrollment data
HIV test kits
Shipping for HIV test kits
Staff/personnel time to manage mailing/return of test kits
Other general and administrative time, office supplies, equipment, rents, utilities
Month 1
Primary Cost of different online venues for identifying new HIV diagnoses The cost (in US dollars) of identifying established HIV infections will be compared between the study arms. The costs involved with identifying established HIV infections include:
Online banner advertisement placement
Study staff time managing enrollment, validating participant eligibility, monitoring and evaluation of enrollment data
HIV test kits
Shipping for HIV test kits
Staff/personnel time to manage mailing/return of test kits
Study staff time to manage monitoring and evaluation of HIV test result data
Study staff time to provide phone counseling to those with established infections
Other general and administrative time, office supplies, equipment, rents, utilities
Month 1
Secondary Cost of linkage to HIV counseling The cost (in US dollars) of linking participants testing positive for HIV to HIV counseling will be compared between the study arms, including:
Study staff time spent contacting participants
Study staff time for intervention maintenance (e.g., app management)
HIV counseling costs to the healthcare system
Other general and administrative time, office supplies, equipment, rents, utilities
Month 4
Secondary Cost of linkage to HIV treatment The cost (in US dollars) of linking participants testing positive for HIV to HIV treatment will be compared between the three study arms, including:
Study staff time for intervention maintenance (e.g., app management)
HIV treatment costs to the healthcare system
Other general and administrative time, office supplies, equipment, rents, utilities
Month 4
Secondary Cost of linkage to PrEP counseling The cost (in US dollars) of linking participants testing negative for HIV to PrEP counseling will be compared between the study arms, including:
Study staff time contacting participants
Study staff time for intervention maintenance (e.g., app management)
PrEP counseling costs to the healthcare system
Other general and administrative time, office supplies, equipment, rents, utilities
Month 4
Secondary Cost of linkage to PrEP uptake The cost (in US dollars) of linking participants testing negative for HIV to initiate PrEP treatment will be compared between the study arms, including:
Study staff time contacting participants
Study staff time for intervention maintenance (e.g., app management)
PrEP uptake costs to the healthcare system
Other general and administrative time, office supplies, equipment, rents, utilities
Month 4
Secondary Cost of Sexually Transmitted Infection (STI) testing The cost (in US dollars) of providing at-home STI testing be compared between the study arms, including:
Cost of STI testing materials and shipping
Laboratory STI testing
Study staff time processing orders and contacting participants
Study staff time for intervention maintenance (e.g., app management)
STI testing costs to the healthcare system
Other general and administrative time, office supplies, equipment, rents, utilities
Month 4
Secondary Cost of linkage to STI treatment The cost (in US dollars) of providing treatment for STIs discovered through at-home STI testing be compared between the three study arms, including:
Study staff time processing orders and contacting participants
Study staff time for intervention maintenance (e.g., app management)
STI treatment costs to the healthcare system
Other general and administrative time, office supplies, equipment, rents, utilities
Month 4
See also
  Status Clinical Trial Phase
Completed NCT03413696 - Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
Completed NCT03215901 - Life Plans Intervention Study N/A
Completed NCT03289676 - Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV Phase 1
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Active, not recruiting NCT04064567 - Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK N/A
Completed NCT04013295 - Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya N/A
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT03984136 - HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM N/A
Completed NCT02928900 - Patient Actor Training to Improve HIV Services for Adolescents in Kenya N/A
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT02797262 - Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System N/A
Completed NCT02376582 - Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS Phase 1
Completed NCT01957865 - Real-Time Antiretroviral Therapy Adherence Intervention in Uganda N/A
Completed NCT01616940 - Minority AIDS Initiative Retention and Re-Engagement Project N/A
Terminated NCT01443923 - Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV Phase 4
Completed NCT01910714 - Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth N/A
Completed NCT01084421 - A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos N/A
Completed NCT01596322 - International HIV Antiretroviral Adherence, Resistance and Survival N/A
Completed NCT03643705 - A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention N/A
Completed NCT03923231 - Pharmacokinetics of Atazanavir in Special Populations